Barrett & Company’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Barrett & Company’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$182K	Hold	905	–	–	0.06%	161
2025 Q4	$187K	Hold	905	–	–	0.06%	156
2025 Q3	$162K	Hold	905	–	–	0.06%	170
2025 Q2	$146K	Sell	905 -55	-6%	-$8.76K	0.05%	173
2025 Q1	$163K	Hold	960	–	–	0.07%	150
2024 Q4	$160K	Hold	960	–	–	0.07%	153
2024 Q3	$165K	Hold	960	–	–	0.07%	150
2024 Q2	$148K	Hold	960	–	–	0.07%	158
2024 Q1	$148K	Hold	960	–	–	0.07%	154
2023 Q4	$152K	Hold	960	–	–	0.08%	143
2023 Q3	$140K	Hold	960	–	–	0.08%	142
2023 Q2	$147K	Hold	960	–	–	0.09%	144
2023 Q1	$149K	Hold	960	–	–	0.09%	143
2022 Q4	$148K	Hold	960	–	–	0.1%	134
2022 Q3	$148K	Buy	+960	New	+$135K	0.1%	134

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Barrett & Company's FBT Position: Q1 2026 in Review

Barrett & Company held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 905 shares worth $182K. The position accounts for 0.06% of the portfolio, ranked #161.

Barrett & Company first reported a position in FBT in Q3 2022 and has held it in 15 quarters since. The position peaked at $187K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Barrett & Company held 905 shares of First Trust NYSE Arca Biotechnology Index Fund worth $182K as of Q1 2026.
Barrett & Company left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.06% of Barrett & Company's portfolio in Q1 2026, its #161 holding.
Barrett & Company first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2022 and has held it in 15 quarters since.
Barrett & Company's First Trust NYSE Arca Biotechnology Index Fund position peaked at $187K in Q4 2025.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Barrett & Company's 13F filing for Q1 2026, filed 4 May 2026.